Outcomes of Six-Dose High-Dose Cytarabine as a Salvage Regimen for Patients with Relapsed/Refractory Acute Myeloid Leukemia

Lignende værker

• High dose cytarabine, mitoxantrone and L-asparaginase (HAMA) salvage for relapsed or refractory acute myeloid leukemia (AML) in the elderly
  af: Ahmed, Tamjeed, et al.
  Udgivet: (2015)
• Reassessing the role of high dose cytarabine and mitoxantrone in relapsed/refractory acute myeloid leukemia
  af: Canaani, Jonathan, et al.
  Udgivet: (2020)
• Salvage Therapy for Relapsed or Refractory Acute Myeloid Leukemia
  af: Mangan, James K., et al.
  Udgivet: (2011)
• Comparison of High-Dose Cytarabine, Mitoxantrone, and Pegaspargase (HAM-pegA) to High-Dose Cytarabine, Mitoxantrone, Cladribine, and Filgrastim (CLAG-M) as First-Line Salvage Cytotoxic Chemotherapy for Relapsed/Refractory Acute Myeloid Leukemia
  af: Ciera L. Patzke, et al.
  Udgivet: (2020-02-01)
• Comparison of High-Dose Cytarabine, Mitoxantrone, and Pegaspargase (HAM-pegA) to High-Dose Cytarabine, Mitoxantrone, Cladribine, and Filgrastim (CLAG-M) as First-Line Salvage Cytotoxic Chemotherapy for Relapsed/Refractory Acute Myeloid Leukemia
  af: Patzke, Ciera L., et al.
  Udgivet: (2020)